Rayonier benefits from strong timberland portfolio and biogenetics advancements, despite competition and market challenges.

From Zacks Investment Research: 2025-03-14 11:16:46

Rayonier Inc. (RYN) is benefiting from a strong timberland portfolio in key regions and advancements in biogenetics. The company recently announced the sale of its New Zealand joint venture interest for $710 million to focus on core U.S. markets. Rayonier’s focus on higher-and-better-use development and balance sheet strengthening are positive indicators for future growth. However, competition from national and local players, as well as market headwinds in the Pacific Northwest, pose challenges. Despite these hurdles, Rayonier remains optimistic about its rural land sales program and development projects, supported by its strong liquidity position and balance sheet improvements.



Read more at Zacks Investment Research: Is it Wise to Retain Rayonier Stock in Your Portfolio Now? – March 14, 2025